Anti-VSIG10 monoclonal antibody

Pre-made anti-VSIG10 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to VSIG10/VSIG10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2263-Ab-1/ GM-Tg-hg-IP2263-Ab-2Anti-Human VSIG10 monoclonal antibodyHuman
GM-Tg-rg-IP2263-Ab-1/ GM-Tg-rg-IP2263-Ab-2Anti-Rat VSIG10 monoclonal antibodyRat
GM-Tg-mg-IP2263-Ab-1/ GM-Tg-mg-IP2263-Ab-2Anti-Mouse VSIG10 monoclonal antibodyMouse
GM-Tg-cynog-IP2263-Ab-1/ GM-Tg-cynog-IP2263-Ab-2Anti-Cynomolgus/ Rhesus macaque VSIG10 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2263-Ab-1/ GM-Tg-felg-IP2263-Ab-2Anti-Feline VSIG10 monoclonal antibodyFeline
GM-Tg-cang-IP2263-Ab-1/ GM-Tg-cang-IP2263-Ab-2Anti-Canine VSIG10 monoclonal antibodyCanine
GM-Tg-bovg-IP2263-Ab-1/ GM-Tg-bovg-IP2263-Ab-2Anti-Bovine VSIG10 monoclonal antibodyBovine
GM-Tg-equg-IP2263-Ab-1/ GM-Tg-equg-IP2263-Ab-2Anti-Equine VSIG10 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2263-Ab-1/ GM-Tg-hg-IP2263-Ab-2; GM-Tg-rg-IP2263-Ab-1/ GM-Tg-rg-IP2263-Ab-2;
GM-Tg-mg-IP2263-Ab-1/ GM-Tg-mg-IP2263-Ab-2; GM-Tg-cynog-IP2263-Ab-1/ GM-Tg-cynog-IP2263-Ab-2;
GM-Tg-felg-IP2263-Ab-1/ GM-Tg-felg-IP2263-Ab-2; GM-Tg-cang-IP2263-Ab-1/ GM-Tg-cang-IP2263-Ab-2;
GM-Tg-bovg-IP2263-Ab-1/ GM-Tg-bovg-IP2263-Ab-2; GM-Tg-equg-IP2263-Ab-1/ GM-Tg-equg-IP2263-Ab-2
Products NameAnti-VSIG10 monoclonal antibody
Formatmab
Target NameVSIG10
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-VSIG10 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2263-Ag-1Recombinant multi-species VSI10/ VSIG10 protein
    ORF Viral VectorvGMLP001179human VSIG10 Lentivirus particle
    ORF Viral VectorpGMLP001179human VSIG10 Lentivirus plasmid


    Target information

    Target IDGM-IP2263
    Target NameVSIG10
    Gene ID54621,231668,304529,107001041,486292,101100599,523257,100054850
    Gene Symbol and SynonymsRGD1565800,VSIG10
    Uniprot AccessionQ8N0Z9
    Uniprot Entry NameVSI10_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000176834
    Target ClassificationN/A

    The target: VSIG10, gene name: VSIG10, also named as . Predicted to enable cell adhesion molecule binding activity. Predicted to be involved in cell-cell adhesion. Predicted to be active in cell-cell junction. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.